GPP

Great Point Partners Portfolio holdings

AUM $154M
This Quarter Return
-12.43%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$184M
AUM Growth
+$184M
Cap. Flow
+$14.6M
Cap. Flow %
7.92%
Top 10 Hldgs %
55.21%
Holding
36
New
9
Increased
6
Reduced
8
Closed
4

Top Buys

1
AKBA icon
Akebia Therapeutics
AKBA
$9.55M
2
ASND icon
Ascendis Pharma
ASND
$7.79M
3
AMLX icon
Amylyx Pharmaceuticals
AMLX
$6.41M
4
IMVT icon
Immunovant
IMVT
$6.41M
5
LEGN icon
Legend Biotech
LEGN
$4.69M

Top Sells

1
KALV icon
KalVista Pharmaceuticals
KALV
$8.92M
2
IONS icon
Ionis Pharmaceuticals
IONS
$7.69M
3
JSPR icon
Jasper Therapeutics
JSPR
$6.89M
4
ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
$4.44M
5
DVAX icon
Dynavax Technologies
DVAX
$3.43M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RZLT icon
26
Rezolute
RZLT
$630M
$2.42M 1.28%
833,042
+211,148
+34% +$612K
CNTA
27
Centessa Pharmaceuticals
CNTA
$2.13B
$2.15M 1.14%
+149,702
New +$2.15M
VYGR icon
28
Voyager Therapeutics
VYGR
$204M
$2.12M 1.12%
626,275
-200,476
-24% -$678K
PMN icon
29
ProMIS Neurosciences
PMN
$23.7M
$1.84M 0.97%
2,645,128
– –
UPB
30
Upstream Bio, Inc. Common Stock
UPB
$1.08B
$1.84M 0.97%
300,000
– –
PLRX icon
31
Pliant Therapeutics
PLRX
$105M
$1.15M 0.61%
850,000
-205,000
-19% -$277K
JSPR icon
32
Jasper Therapeutics
JSPR
$44.2M
– –
-322,380
Closed -$6.89M
OPTN
33
DELISTED
OptiNose
OPTN
– –
-370,269
Closed -$2.47M
SMMT icon
34
Summit Therapeutics
SMMT
$17.5B
– –
0
– –
URGN icon
35
UroGen Pharma
URGN
$896M
– –
-187,843
Closed -$2M
ORKA
36
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
– –
-228,803
Closed -$4.44M
1
2